Next, to further evaluate the accuracy of the HPA database, we used immunohistochemistry to assess the protein levels of OPA3 detected in TMA using human ovarian cancer tissue microarray (TMA) at different stages. This evidence concerns the gene OPA3 and ovarian carcinoma.